Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia.
- DOI
- 10.1007/s12325-026-03522-6
- Published
- 2026 Apr
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03522-6,
title = {Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia.},
author = {Watts JM and Wang ES and Jonas BA and Wilson FR and Park JE and Cope S and Sheppard A and Thomassen A and de Botton S and Cortes JE},
year = {2026},
journal = {Advances in therapy},
doi = {10.1007/s12325-026-03522-6},
url = {https://doi.org/10.1007/s12325-026-03522-6}
}RIS
TY - JOUR TI - Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia. AU - Watts JM AU - Wang ES AU - Jonas BA AU - Wilson FR AU - Park JE AU - Cope S AU - Sheppard A AU - Thomassen A AU - de Botton S AU - Cortes JE PY - 2026 JO - Advances in therapy DO - 10.1007/s12325-026-03522-6 UR - https://doi.org/10.1007/s12325-026-03522-6 ER -
APA
JM, W., ES, W., BA, J., FR, W., JE, P., S, C., A, S., A, T., S, D. B., & JE, C. (2026). Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia.. Advances in therapy. https://doi.org/10.1007/s12325-026-03522-6
Source records
- pubmed · retrieved 2026-09-26T22:38:50.765Z